DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE

2754 reported adverse events

Drug classes: Cytochrome P450 3A Inhibitor [EPC] Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Protease Inhibitor [EPC]

These side effects are most commonly reported by patients taking DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE:

# Side effect Count
0 BONE DENSITY DECREASED 1067
1 BONE LOSS 609
2 OSTEONECROSIS 608
3 CHRONIC KIDNEY DISEASE 578
4 TOOTH LOSS 565
5 MULTIPLE FRACTURES 529
6 RENAL FAILURE 509
7 OSTEOPOROSIS 433
8 RENAL INJURY 426
9 SKELETAL INJURY 373
See all common reactions for DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE

DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ASPIRATION BURSA 2 0.2857
1 CYTOMEGALOVIRUS PANCREATITIS 2 0.2000
2 CYSTIC FIBROSIS CARRIER 1 0.1429
3 NEUROENDOCRINE TUMOUR METASTATIC 1 0.1111
4 BLOOD HIV RNA 5 0.0962
5 PROCTITIS CHLAMYDIAL 1 0.0909
6 SACRAL RADICULOPATHY 1 0.0714
7 TESTICULAR OPERATION 4 0.0714
8 CORONARY OSTIAL STENOSIS 8 0.0635
9 RECTAL ATRESIA 1 0.0476
See all enriched reactions for DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE